Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Trial of Imatinib for Hospitalized Adults With COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Trial of Imatinib for Hospitalized Adults With COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04394416).
- Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Trial of IRE in Cholangiocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of IRE in Cholangiocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03769753).
- Trial of L-DOPA as a Treatment to Improve Vision in Albinism: Complete Statistical AnalysisIndependent statistical analysis of Trial of L-DOPA as a Treatment to Improve Vision in Albinism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Trial of LBH589 in Metastatic Thyroid Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of LBH589 in Metastatic Thyroid Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01013597).
- Trial of Linaclotide in Patients With Chronic Constipation: Complete Statistical AnalysisIndependent statistical analysis of Trial of Linaclotide in Patients With Chronic Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00730015).
- Trial of Linaclotide in Patients With Chronic Idiopathic Constipation: Complete Statistical AnalysisIndependent statistical analysis of Trial of Linaclotide in Patients With Chronic Idiopathic Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02291679).
- Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): Complete Statistical AnalysisIndependent statistical analysis of Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial of Low and High Intensity Strategies to Maintain BP Control: Complete Statistical AnalysisIndependent statistical analysis of Trial of Low and High Intensity Strategies to Maintain BP Control: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release: Complete Statistical AnalysisIndependent statistical analysis of Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI: Complete Statistical AnalysisIndependent statistical analysis of Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas: Complete Statistical AnalysisIndependent statistical analysis of Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.: Complete Statistical AnalysisIndependent statistical analysis of Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03658304).
- Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors: Complete Statistical AnalysisIndependent statistical analysis of Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors: primary endpoint…
- Trial of NanoPac Focal Therapy for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of NanoPac Focal Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04221828).
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL: Complete Statistical AnalysisIndependent statistical analysis of Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of Nivolumab as a Novel Neoadjuvant Pre-Surgical Therapy for Locally Advanced Oral Cavity Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial of Nivolumab vs Therapy of Investigator’s Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141): Complete Statistical AnalysisIndependent statistical analysis of Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Trial Of NS2359 For The Treatment of Cocaine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Trial Of NS2359 For The Treatment of Cocaine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02798627).
- Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II): Complete Statistical AnalysisIndependent statistical analysis of Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553254).
- Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain: Complete Statistical AnalysisIndependent statistical analysis of Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03407430).
- Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients: Complete Statistical AnalysisIndependent statistical analysis of Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial of Quetiapine in Anorexia Nervosa: Complete Statistical AnalysisIndependent statistical analysis of Trial of Quetiapine in Anorexia Nervosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00518973).
- Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial of RAD001 in Triple Negative Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of RAD001 in Triple Negative Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00827567).
- Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy: Complete Statistical AnalysisIndependent statistical analysis of Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02579161).
- Trial of Rifaximin in the Treatment of Tropical Enteropathy: Complete Statistical AnalysisIndependent statistical analysis of Trial of Rifaximin in the Treatment of Tropical Enteropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00858988).
- Trial of Scrambler Therapy or Sham Treatment for Low Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Trial of Scrambler Therapy or Sham Treatment for Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Trial of Sertraline to Treat Children With Fragile X Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Trial of Sertraline to Treat Children With Fragile X Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01474746).
- Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age: primary endpoint…
- Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers: Complete Statistical AnalysisIndependent statistical analysis of Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers: primary endpoint results, effect estimate with confidence interval, sample-size…
- Trial of TRC105 and Sorafenib in Patients With HCC: Complete Statistical AnalysisIndependent statistical analysis of Trial of TRC105 and Sorafenib in Patients With HCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02560779).
- Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India: Complete Statistical AnalysisIndependent statistical analysis of Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01091168).
- Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma: Complete Statistical AnalysisIndependent statistical analysis of Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Trial on the Effect of E-cigarette Advertising on Cigarette Perceptions in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Trial on the Effect of E-cigarette Advertising on Cigarette Perceptions in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Trial to Assess Chelation Therapy (TACT): Complete Statistical AnalysisIndependent statistical analysis of Trial to Assess Chelation Therapy (TACT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00044213).
- Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee: Complete Statistical AnalysisIndependent statistical analysis of Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183): Complete Statistical AnalysisIndependent statistical analysis of Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates: Complete Statistical AnalysisIndependent statistical analysis of Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease: Complete Statistical AnalysisIndependent statistical analysis of Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Trial to Evaluate CIS43LS in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Trial to Evaluate CIS43LS in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04206332).
- Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…